|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
You can purchase shares of Better Therapeutics (NASDAQ: BTTX) through any online brokerage.
There are no as such competitors for Better Therapeutics.
The latest price target for Better Therapeutics (NASDAQ: BTTX) was reported by Chardan Capital on November 24, 2021. The analyst firm set a price target for 17.00 expecting BTTX to rise to within 12 months (a possible 135.78% upside). 2 analyst firms have reported ratings in the last year.
The stock price for Better Therapeutics (NASDAQ: BTTX) is $7.21 last updated Fri Nov 26 2021 18:00:03 GMT+0000 (Coordinated Universal Time).
There are no upcoming dividends for Better Therapeutics.
Better Therapeutics’s $Q4 earnings are confirmed for after-market on February 19, 2022.
There is no upcoming split for Better Therapeutics.
Better Therapeutics is in the sector and industry. They are listed on the NASDAQ.